<DOC>
	<DOCNO>NCT01783392</DOCNO>
	<brief_summary>This clinical trial test three different site transcutaneous electrical nerve stimulation treatment overactive bladder ( OAB ) .</brief_summary>
	<brief_title>Peripheral Electrical Stimulation Treatment Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<criteria>Males Females , least 18 year age Documented symptom idiopathic overactive bladder least 3 month Failure primary OAB treatment , behavior modification fluid/diet management Patients remain stable medication Willing capable understanding complying requirement protocol Signed Informed Consent participate study full discussion research nature treatment risk benefit Urinary retention post void residual great 100 ml Clinically significant bladder outlet obstruction Stress predominant mix urinary incontinence Neurological disease affect urinary bladder function , include limited Parkinson 's disease , multiple sclerosis , stroke , spinal cord injury . Pelvic surgery ( suburethral sling , pelvic floor repair ) within past 6 month Denovo OAB follow pelvic surgery suburethral sling Intravesical urethral sphincter Botulinum Toxin Type A injection within past 6 month Percutaneous Tibial Nerve Stimulation ( PTNS ) therapy overactive bladder within past 6 month Any form electric stimulation pelvis lower limb within 4 week Vaginal prolapse great Stage II anterior compartment vagina use International Continence Society ( ICS ) Pelvic Organ ProlapseQuantification ( POPQ ) criterion . Prior periurethral transurethral bulking agent injection bladder problem within past 12 month . History pelvic radiation therapy Any skin condition affect treatment site Lacking dexterity properly utilize component stimulator system . Presence implant electromedical device ( e.g . pacemaker , defibrillator , InterStimÂ® , etc . ) , Pregnant , nursing , suspect pregnant ( urine pregnancy method ) , plan become pregnant course study . Recurrent Urinary Tract Infections UTI ( &gt; 3 UTI 's past year ) History , current , low tract genitourinary malignancy Any clinically significant systemic disease condition opinion Investigator would make patient unsuitable study Any clinical trial within 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>overactive bladder</keyword>
	<keyword>transcutaneous posterior tibial nerve stimulation</keyword>
	<keyword>placebo PTNS</keyword>
</DOC>